Drug Type Small molecule drug |
Synonyms GLPG-2534, GLPG2534 |
Target |
Action inhibitors |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H24N6O4 |
InChIKeyVNAPWQDUDZCVCA-UHFFFAOYSA-N |
CAS Registry2095615-97-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| inflammatory dermatosis | Preclinical | France | 15 Feb 2023 | |
| Dermatitis, Atopic | Preclinical | Belgium | - |





